Woman reading in MDC library

Scientific Publications

734 Results:
Active Filter:
Sort:
/ Circulation

Extracellular matrix in heart failure: role of ADAMTS5 in proteoglycan remodeling

  • J. Barallobre-Barreiro
  • T. Radovits
  • M. Fava
  • U. Mayr
  • W.Y. Lin
  • E. Ermolaeva
  • D. Martínez-López
  • E.L. Lindberg
  • E. Duregotti
  • L. Daróczi
  • M. Hasman
  • L.E. Schmidt
  • B. Singh
  • R. Lu
  • F. Baig
  • A.M. Siedlar
  • F. Cuello
  • N. Catibog
  • K. Theofilatos
  • A.M. Shah
  • M.G. Crespo-Leiro
  • N. Doménech
  • N. Hübner
  • B. Merkely
  • M. Mayr
/ Hypertension

Blood pressure-independent effects in rats with human renin and angiotensinogen genes

  • E. Mervaalo
  • D.N. Mueller
  • F. Schmidt
  • J.K. Park
  • V. Gross
  • M. Bader
  • V. Breu
  • D. Ganten
  • H. Haller
  • F.C. Luft
/ J Am Soc Nephrol

New aspects in the pathophysiology of preeclampsia

  • J.M. Davison
  • V. Homuth
  • A. Jeyabalan
  • K.P. Conrad
  • S.A. Karumanchi
  • S. Quaggin
  • R. Dechend
  • F.C. Luft
/ Fibrinolysis

Update on the toxicology and pharmacology of rDSPA alpha 1 (Bat-PA) in animals and humans

  • D.C. Gulba
  • M. Praus
  • R. Dechend
  • S. Hauck
  • M. Mahler
  • R. Zitvz
  • B. Baldus
  • W. Mueller
  • R. Dietz
/ Circulation

AT1 receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor

  • R. Dechend
  • V. Homuth
  • G. Wallukat
  • J. Kreuzer
  • J.K. Park
  • J. Theuer
  • A. Juepner
  • D.C. Gulba
  • N. Mackman
  • H. Haller
  • F.C. Luft
/ Am J Pathol

Angiotensin II (AT1) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy

  • D.N. Mueller
  • E.M.A. Mervaala
  • R. Dechend
  • A. Fiebeler
  • J.K. Park
  • F. Schmidt
  • J. Theuer
  • V. Breu
  • N. Mackman
  • T. Luther
  • W. Schneider
  • D. Gulba
  • D. Ganten
  • H. Haller
  • F.C. Luft
/ MMW Fortschr Med

Antihypertensive Behandlung. Bei Risikopatienten von Anfang an fix kombinieren [Fixed-dose combinations in antihypertensive treatment: is it necessary to examine the effectiveness of each component?]

  • R. Dechend
  • W. Derer
  • D.N. Mueller
/ Clin J Am Soc Nephrol

New approaches to pathogenesis and management of hypertension

  • E. Ritz
  • H. Krum
  • M. Schlaich
  • R. Whitbourn
  • P.A. Sobotka
  • J. Sadowski
  • K. Bartus
  • B. Kapelak
  • A. Walton
  • H. Sievert
  • S. Thambar
  • W.T. Abraham
  • M. Esler
  • Y. Wang
  • Z. Tsun
  • A. Machnik
  • W. Neuhofer
  • J. Jantsch
  • A. Dahlmann
  • T. Tammela
  • K. Machura
  • J.K. Park
  • F.X. Beck
  • D.N. Mueller
  • W. Derer
  • J. Goss
  • A. Ziomber
  • P. Dietsch
  • H. Wagner
  • N. van Rooijen
  • A. Kurtz
  • K.F. Hilgers
  • K. Alitalo
  • K.U. Eckardt
  • F.C. Luft
  • D. Kerjaschki
  • J. Titze
/ Trends Cardiovasc Med

Role of the immune system in hypertensive target organ damage

  • H. Kvakan
  • F.C. Luft
  • D.N. Mueller
/ J Neurol

Clinical and genetic features in a family with CADASIL and high lipoprotein (a) values

  • M. Gong
  • F. Rueschendorf
  • P. Marx
  • H. Schulz
  • H.G. Kraft
  • N. Huebner
  • H.C. Koennecke